Extranodal Non-Hodgkin Lymphoma — Trials

Extranodal Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

261 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 13%
Top sponsor: Ruijin Hospital
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05003141	PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies	unknown	Phase 1	110	Qilu Puget Sound Biotherapeutics (dba Sound Biologics)INDUSTRY	3	Mar 28, 2022	clinicaltrials
NCT03999697	A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies	unknown	Phase 1	10	PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY	1	Jun 27, 2019	clinicaltrials